|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.990 USD | -3.11% |
|
+7.08% | -8.74% |
| 03-12 | Bolt Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 03-11 | Bolt Biotherapeutics, Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Capitalization | 9.59M 8.17M 7.49M 7.1M 13.1M 896M 13.41M 88.09M 34.59M 431M 35.96M 35.22M 1.53B | P/E ratio 2026 * |
-0.26x | P/E ratio 2027 * | -0.4x |
|---|---|---|---|---|---|
| Enterprise value | 9.59M 8.17M 7.49M 7.1M 13.1M 896M 13.41M 88.09M 34.59M 431M 35.96M 35.22M 1.53B | EV / Sales 2026 * |
4.11x | EV / Sales 2027 * | 2.74x |
| Free-Float |
96.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bolt Biotherapeutics, Inc.
| 1 day | -3.11% | ||
| 1 week | +7.08% | ||
| Current month | +23.51% | ||
| 1 month | +4.83% | ||
| 3 months | -20.03% | ||
| 6 months | -14.85% | ||
| Current year | -8.74% |
| 1 week | 4.66 |  | 5.62 |
| 1 month | 4.03 | | 5.62 |
| Current year | 3.91 | | 7.2 |
| 1 year | 3.91 | | 9.25 |
| 3 years | 3.91 | | 40.6 |
| 5 years | 3.91 | | 552.6 |
| 10 years | 3.91 | | 861.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Alonso
CTO | Chief Tech/Sci/R&D Officer | - | 14/05/2024 |
William Quinn
CEO | Chief Executive Officer | 54 | 14/05/2024 |
Grant Yonehiro
COO | Chief Operating Officer | 61 | 14/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Kathy LaPorte
BRD | Director/Board Member | 64 | 30/11/2020 |
William Quinn
BRD | Director/Board Member | 54 | 14/05/2024 |
| Chairman | 55 | 03/09/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.11% | +7.08% | -28.71% | -84.69% | 9.9M | |
| -3.00% | +1.39% | +30.94% | +97.92% | 51.85B | |
| -1.21% | -6.77% | +86.47% | +26.14% | 44.26B | |
| -1.29% | -6.72% | +94.05% | +696.50% | 30.83B | |
| +6.09% | +15.41% | +13.00% | -7.72% | 26.6B | |
| +5.02% | +31.70% | +7.19% | +1,559.12% | 19.48B | |
| -0.79% | +0.06% | +72.20% | -32.31% | 18.8B | |
| -0.14% | +6.46% | +76.85% | +238.80% | 17.28B | |
| -2.42% | -3.54% | +34.11% | -37.70% | 17.18B | |
| -1.09% | +2.73% | +75.37% | - | 15.07B | |
| Average | -0.19% | +4.62% | +46.15% | +272.89% | 24.14B | |
| Weighted average by Cap. | -0.27% | +2.56% | +54.79% | +268.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.33M 1.99M 1.82M 1.73M 3.19M 218M 3.26M 21.44M 8.42M 105M 8.75M 8.57M 372M | 3.5M 2.98M 2.73M 2.59M 4.78M 327M 4.89M 32.15M 12.63M 157M 13.13M 12.86M 558M |
| Net income | -37.36M -31.82M -29.17M -27.67M -51.04M -3.49B -52.24M -343M -135M -1.68B -140M -137M -5.96B | -23.75M -20.23M -18.54M -17.59M -32.44M -2.22B -33.21M -218M -85.68M -1.07B -89.07M -87.23M -3.79B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/04/26 | 4.990 $ | -3.11% | 14,439 |
| 20/04/26 | 5.150 $ | +8.88% | 63,257 |
| 17/04/26 | 4.730 $ | -1.66% | 9,158 |
| 16/04/26 | 4.810 $ | -2.04% | 9,797 |
| 15/04/26 | 4.910 $ | +3.59% | 9,842 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BOLT Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition